Spero Therapeutics Inc. (SPRO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Spero Therapeutics Inc.

    NASDAQ: SPRO · Real-Time Price · USD
    2.02
    -0.13 (-6.05%)
    At close: Sep 08, 2025, 2:55 PM

    Spero Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 52.89M 76.33M 109.11M 112.58M
    Short-Term Investments
    		 n/a n/a n/a 33.82M
    Long-Term Investments
    		 n/a 46.59M n/a n/a
    Other Long-Term Assets
    		 153K 435K 10.2M 5.64M
    Receivables
    		 52.48M 50.7M 1.08M 2.64M
    Inventory
    		 n/a n/a -4.46M n/a
    Other Current Assets
    		 1.91M n/a 3.38M n/a
    Total Current Assets
    		 107.28M 131.21M 109.11M 157.87M
    Property-Plant & Equipment
    		 3.11M 4.16M 5.49M 7.56M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 3.27M 51.18M 15.7M 13.2M
    Total Assets
    		 110.54M 182.39M 124.8M 171.07M
    Account Payables
    		 7.31M 1.38M 617K 1.1M
    Deferred Revenue
    		 22.12M 27.11M 10.37M 1.86M
    Short-Term Debt
    		 n/a 1.72M 1.69M 1.36M
    Other Current Liabilities
    		 n/a 1.5M -1.24M 7.1M
    Total Current Liabilities
    		 49.07M 37.15M 21.65M 18.67M
    Long-Term Debt
    		 n/a n/a n/a 48.41M
    Other Long-Term Liabilities
    		 576K 23.69M 96K 940K
    Total Long-Term Liabilities
    		 15.35M 38.34M 27.22M 64.11M
    Total Liabilities
    		 64.42M 75.5M 48.87M 82.78M
    Total Debt
    		 4.3M 5.54M 6.65M 55.75M
    Common Stock
    		 55K 53K 52K 32K
    Retained Earnings
    		 -459.64M -391.07M -413.88M -367.46M
    Comprehensive Income
    		 n/a n/a n/a -2K
    Shareholders Equity
    		 46.12M 106.89M 75.93M 88.29M
    Total Investments
    		 n/a 46.59M n/a 33.82M

    Add to Watchlist